Research hotspots and advances in atherosclerotic plaque regression: A bibliometric analysis

Zequn Fu1, Yu Bin1, Xinyun Zhang2

  • 1School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.

Medicine
|December 10, 2025
PubMed
Abstract

Insights

Research on atherosclerotic plaque regression is rapidly advancing, focusing on lipid metabolism, inflammation, and new therapies like statins and PCSK9 inhibitors. Future work aims to translate these findings for cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Research
  • Medical Science

Background:

  • Atherosclerotic plaque regression is crucial for preventing cardiovascular diseases (CVDs).
  • Rapid advancements in therapies and imaging necessitate comprehensive field analysis.

Purpose of the Study:

  • To systematically analyze research status, hotspots, and trends in atherosclerotic plaque regression from 2000-2025.
  • To guide future research directions in this evolving field.

Main Methods:

  • Bibliometric analysis of 4725 publications from Web of Science Core Collection.
  • Utilized VOSviewer and CiteSpace for assessing publication output, collaborations, and keyword patterns.

Main Results:

  • Significant upward trend in annual publications (7.8% growth).
  • China and the US lead research contributions.
  • Key research areas include regression mechanisms (lipid metabolism, inflammation), therapies (statins, PCSK9 inhibitors), and imaging (IVUS, OCT).
  • Research focus is shifting from pathology to targeted interventions.

Conclusions:

  • Atherosclerotic plaque regression research is rapidly progressing.
  • Future directions include enhanced international collaboration, multidisciplinary integration, and incorporating precision medicine.
  • The goal is to translate plaque regression strategies for clinical use and reduce CVD burden.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
795
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
434
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
340
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
847
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
288